WASHINGTON--(BUSINESS WIRE)-- The law firm Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Physicians Formula Holdings, Inc. (NASDAQ GS:FACE) (“Physicians” or “the Company”), concerning the proposed acquisition of the Company by Markwins International Corporation. Under the terms of the transaction, Physicians’ shareholders would receive $4.90 per share in cash. The total value of the transaction is approximately $74.9 million.
Physicians has performed well recently, reporting improved financial results in its filings with the SEC. The investigation is focused on the potential unfairness of the consideration to Physicians’ shareholders, the process by which the Company’s Board of Directors is considering the transaction, and potential conflicts of interest among Physicians’ Board members.
If you are interested in discussing your rights as a Physicians shareholder, or have information relating to this investigation, please contact Finkelstein Thompson’s Washington, DC offices at (202) 337-8000 or by email at email@example.com.
Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.
To learn more about Finkelstein Thompson LLP, please visit our website at www.finkelsteinthompson.com. Attorney advising. Prior results do not guarantee similar outcomes.
Finkelstein Thompson LLP
Rosalee Thomas, 202-337-8000
Source: Finkelstein Thompson LLP